Drug class
Precocious Puberty Agents
Precocious puberty agents refer to a therapeutic category of medications primarily consisting of gonadotropin-releasing hormone agonists, such as leuprolide, histrelin, and triptorelin. Read more about Precocious Puberty Agents
32 drugs in this class 15 manufacturers
Drugs in Precocious Puberty Agents
LUTRATE DEPOT (leuprolide acetate)
VABRINTY (leuprolide acetate)
SUPPRELIN LA (histrelin acetate)
LEUPROLIDE ACETATE
Precocious puberty agents refer to a therapeutic category of medications primarily consisting of gonadotropin-releasing hormone agonists, such as leuprolide, histrelin, and triptorelin.
These agents work by continuously stimulating pituitary GnRH receptors, which paradoxically leads to receptor desensitization and down-regulation, thereby suppressing luteinizing hormone, follicle-stimulating hormone, and downstream gonadal sex steroids to prepubertal levels.
They are indicated for the management of central precocious puberty, where they arrest accelerated somatic development and prevent premature epiphyseal plate fusion to preserve adult stature.
In peripheral precocious puberty, adjunctive therapies such as aromatase inhibitors or androgen receptor blockers may be utilized depending on the underlying endocrine etiology.
-
fda.gov
Precocious puberty agents refer to a therapeutic category of medications primarily consisting of gonadotropin-releasing hormone agonists, such as leuprolide, histrelin, and triptorelin
-
fda.gov
Precocious puberty agents refer to a therapeutic category of medications primarily consisting of gonadotropin-releasing hormone agonists, such as leuprolide, histrelin, and triptorelin These agents work by continuously stimulating pituitary GnRH receptors, which paradoxically leads to receptor desensitization and down-regulation, thereby suppressing luteinizing hormone, follicle-stimulating hormone, and downstream gonadal sex steroids to prepubertal levels They are indicated for the management o...
-
nih.gov
These agents work by continuously stimulating pituitary GnRH receptors, which paradoxically leads to receptor desensitization and down-regulation, thereby suppressing luteinizing hormone, follicle-stimulating hormone, and downstream gonadal sex steroids to prepubertal levels
-
fda.gov
They are indicated for the management of central precocious puberty, where they arrest accelerated somatic development and prevent premature epiphyseal plate fusion to preserve adult stature
-
nih.gov
In peripheral precocious puberty, adjunctive therapies such as aromatase inhibitors or androgen receptor blockers may be utilized depending on the underlying endocrine etiology
-
nih.gov
In peripheral precocious puberty, adjunctive therapies such as aromatase inhibitors or androgen receptor blockers may be utilized depending on the underlying endocrine etiology
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.